Vesteck, Inc.

Funding and NIH signals

• SEC Form D raise Raised $354K (Form D filed Oct 30, 2025). SEC Form D 0001882165-25-000002 (Oct 30, 2025)
  Evidence (1 event)

  • Oct 30, 2025 · SEC Form D 0001882165-25-000002
    Name of Issuer: VESTECK, INC.; CIK: 1882165; Address: Carlsbad, CA; Submission type: D; Filing date: 2025-10-30; Industry Group: Other Technology; Date of First Sale: 2025-10-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 500000; Total Amount Sold: 353578; Federal exemptions: 06b
• NIH award NIH awarded $624K (SBIR Phase II 5R44HL178318-02, continuation, notice Sep 11, 2026). NIH RePORTER 5R44HL178318-02 (Sep 11, 2026)
  Evidence (1 event)

  • Sep 11, 2026 · NIH RePORTER 5R44HL178318-02
    Organization: VESTECK, INC; City/State: Malvern, PA; Project number: 5R44HL178318-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-11; FY total cost (award amount): 624389; Administering IC: National Heart Lung and Blood Institute; Project title: Endovascular Suturing Device for Augmentation of Endograft Fixation During Endovascular Repair of Abdominal Aortic Aneurysm to Reduce Reinterventions Due to Endograft Migration or Type 1a Endoleak; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals